SiNtx Technologies, Inc.
SINTSiNtx Technologies, Inc. in brief
SiNtx Technologies, Inc. is a listed company in the Medical Devices industry, based in Salt Lake City, Utah, USA. Its market value was $13 M on 30 October 2026, which makes it the 25,359th largest listed company in the world and the 4,236th largest in the USA on this site. In the year to December 2025 it had sales of $1 M and a net loss of $10 M. It employs about 32 people and Eric K. Olson is its chief executive. Its largest product and service lines by sales in 2025 were Grant and Contract (28%). Its shares trade under the symbol SINT (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About SiNtx Technologies, Inc.
SINTX Technologies is an advanced ceramics company formed in December 1996 that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. SINTX provides biomedical solutions for medical devices specializing in silicon nitride (Si₃N₄) for musculoskeletal and antipathogenic applications. We also manufacture parts made from silicon nitride for customers in the electrical, aerospace and other industrial sectors. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008.
From the company's annual report filed with the US SEC: read the report
SiNtx Technologies, Inc. timeline
- 2003
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2014
- 🔔Initial public offering as Amedica CorpFinal prospectus filed with the SEC on 14 February 2014; shares registered for exchange trading on 7 February 2014.
- 2018
- ✎Renamed Sintx Technologies, Inc.Formerly Amedica Corp.
- 2024
- 💰Record revenue of $3 millionFY2024, the highest of the 7 years on record.
Events of SiNtx Technologies, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #4,845 (Jan 2020) · #4,161 (Jan 2021) · #5,488 (Jan 2022) · #5,809 (Dec 2022) · #5,575 (Jul 2023) · #4,726 (Jan 2024) · #2,370 (Mar 2026) · #4,033 (Aug 2026) · #4,160 (Oct 2026) · #4,238 (Oct 2026)
Key ratios
- P/E ratio
- n/m (loss)
- Price / sales
- 12.9×
- Price / book
- 4.5×
- Free cash flow yield
- -66.5%
- Net margin
- -1015.7%
- Operating margin
- -1051.0%
- Return on equity
- -353.6%
- Liabilities / assets
- 69.2%
- Net debt
- $-6M
- Revenue growth
- -64.7%
- R&D / revenue
- 450.0%
- Revenue per employee
- $32 K
- Profit per employee
- $-324 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $1M | -64.7% | $-11M | $-10M | -1015.7% |
| Dec 2024 | $3M | +9.9% | $-14M | $-11M | -381.3% |
| Dec 2023 | $3M | +68.6% | $-13M | $-8M | -314.1% |
| Dec 2022 | $2M | +155.7% | $-11M | $-12M | -771.8% |
| Dec 2021 | $1M | +3.4% | $-11M | $-9M | -1526.2% |
| Dec 2020 | $1M | -14.5% | $-9M | $-7M | -1191.5% |
| Dec 2019 | $1M | — | $-7M | $-5M | -695.7% |
| Dec 2018 | — | — | $-13M | $-9M | — |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-9M | $0M | $-9M | $-6.16 | — |
| Dec 2024 | $-9M | $1M | $-9M | $-15.19 | — |
| Dec 2023 | $-14M | $1M | $-15M | $-624.47 | — |
| Dec 2022 | $-10M | $1M | $-12M | $-60.81 | — |
| Dec 2021 | $-10M | $4M | $-14M | $-39.91 | — |
| Dec 2020 | $-9M | $0M | $-9M | $-1.08 | — |
| Dec 2019 | $-6M | $0M | $-7M | $-5.69 | — |
| Dec 2018 | $-9M | $0M | $-9M | $-76.73 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $2M (+942.9% on a year earlier), net income $-2M. Lighter bars: fourth quarters worked out from the annual report.
SEC filings
- Nov 5, 20268-KCurrent reportResults of operations · Regulation FD disclosure
- Nov 5, 202610-QQuarterly report · period to Sep 2026
- Oct 30, 2026DEF 14AProxy statement
- Oct 9, 20268-KCurrent reportOther events
- Oct 1, 20268-KCurrent reportResults of operations · Regulation FD disclosure
- Aug 13, 20268-KCurrent reportRegulation FD disclosure · Other events
- Aug 11, 20268-KCurrent reportResults of operations · Regulation FD disclosure
- Aug 11, 202610-QQuarterly report · period to Jun 2026
- Jul 23, 20268-KCurrent reportRegulation FD disclosure
- Jul 2, 20268-KCurrent reportMaterial agreement · Unregistered share sale
- Jun 3, 20268-KCurrent reportMaterial agreement · Unregistered share sale · Other events
- May 27, 20268-KCurrent reportListing notice
Official filings of SiNtx Technologies, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $1 M
- Operating income
- $-11 M
- Net income
- $-10 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $10 M
- Total liabilities
- $7 M
- Total equity
- $3 M
As of December-2025
Top 22 institutional investors in SiNtx Technologies, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | Bleichroeder LP | 523,013 | 0 (0.00%) | 6.92% | $1 M | Nov 13, 2026 |
| 2 | Stonepine Capital Management, LLC | 233,936 | +24,731 (+11.82%) | 3.10% | $1 M | Nov 13, 2026 |
| 3 | Veracity Capital LLC | 76,674 | 0 (0.00%) | 1.01% | $0 M | Oct 8, 2026 |
| 4 | Geode Capital Management, LLC | 25,117 | -4,984 (-16.56%) | 0.33% | $0 M | Nov 6, 2026 |
| 5 | Vanguard Fiduciary Trust Co | 23,531 | 0 (0.00%) | 0.31% | $0 M | Nov 13, 2026 |
| 6 | Vanguard Capital Management LLC | 20,905 | 0 (0.00%) | 0.28% | $0 M | Nov 13, 2026 |
| 7 | Citadel Advisors LLC | 17,209 | -14,721 (-46.10%) | 0.23% | $0 M | Nov 16, 2026 |
| 8 | State Street Corp | 13,302 | 0 (0.00%) | 0.18% | $0 M | Nov 12, 2026 |
| 9 | Northern Trust Corp | 10,816 | New | 0.14% | $0 M | Nov 16, 2026 |
| 10 | Virtus Wealth Solutions LLC | 10,000 | 0 (0.00%) | 0.13% | $0 M | Nov 3, 2026 |
| 11 | Tower Research Capital LLC (TRC) | 1,849 | -1,001 (-35.12%) | 0.02% | $0 M | Nov 16, 2026 |
| 12 | UBS Group AG | 1,598 | -10,323 (-86.60%) | 0.02% | $0 M | Nov 10, 2026 |
| 13 | Signaturefd, LLC | 573 | -1,144 (-66.63%) | 0.01% | $0 M | Oct 23, 2026 |
| 14 | FMR LLC | 50 | New | 0.00% | $0 M | Nov 10, 2026 |
| 15 | Royal Bank Of Canada | 40 | +1 (+2.56%) | 0.00% | $0 M | Nov 16, 2026 |
| 16 | SBI Securities Co., Ltd. | 14 | 0 (0.00%) | 0.00% | $0 M | Oct 22, 2026 |
| 17 | US Bancorp \de\ | 1 | New | 0.00% | $0 M | Nov 5, 2026 |
| 18 | Morgan Stanley | 1 | 0 (0.00%) | 0.00% | $0 M | Nov 13, 2026 |
| 19 | National Bank Of Canada /fi/ | 1 | 0 (0.00%) | 0.00% | $0 M | Nov 16, 2026 |
| 20 | Allworth Financial LP | 1 | 0 (0.00%) | 0.00% | $0 M | Nov 17, 2026 |
| 21 | Cassaday & Co Wealth Management LLC | 1 | New | 0.00% | $0 M | Oct 27, 2026 |
| 22 | BFC Planning, Inc. | 1 | 0 (0.00%) | 0.00% | $0 M | Nov 13, 2026 |
Mutual funds holding SiNtx Technologies, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 18,832 | $0 M | 0.25% | <0.01% | −0.8% | May 31, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 20,905 | $0 M | 0.28% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 4,288 | $0 M | 0.06% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 1,861 | $0 M | 0.02% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 1,373 | $0 M | 0.02% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Advisors LLC | 43 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 6 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at SiNtx Technologies, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Robert Ryan ElmorePresident | Grant or award | +4,910 | $2.890 | $14 K | 4,910 | Form 4 |
| filed | Christopher Michael LyonsDirector | Buy | +7,534 | $2.900 | $22 K | 8,292 | Form 4 |
| filed | Christopher Michael LyonsDirector | Buy | +758 | $2.960 | $2 K | 758 | Form 4 |
| filed | Jay M. MoyesDirector | Buy | +1,000 | $2.910 | $3 K | 4,000 | Form 4 |
| filed | Mark Lewis AndersonDirector | Buy | +3,000 | $3.020 | $9 K | 18,000 | Form 4 |
| filed | Gregg R. HonigblumChief Investment Officer, Director | Buy | +3,200 | $4.280 | $14 K | 196,067 | Form 4 |
| filed | Gregg R. HonigblumChief Investment Officer, Director | Buy | +5,000 | $4.240 | $21 K | 201,067 | Form 4 |
| filed | Gregg R. HonigblumChief Investment Officer, Director | Buy | +5,000 | $3.950 | $20 K | 79,000 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: SiNtx Technologies, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Stock splits: 1-for-25.84 reverse split
| Buybacks, quarter | Fiscal | Spent |
|---|---|---|
| Q4 2025 | Q4 2025 | $0M |
| Q3 2025 | Q3 2025 | $0M |
| Q2 2025 | Q2 2025 | $0M |
| Q1 2025 | Q1 2025 | $0.1M |
| Q4 2015 | Q4 2015 | $0M |
| Q3 2015 | Q3 2015 | $0M |
| Q2 2015 | Q2 2015 | $0M |
| Q1 2015 | Q1 2015 | $0.1M |
| Q3 2014 | Q3 2015 | $0M |
| Q2 2014 | Q2 2015 | $0M |
| Q1 2014 | Q1 2015 | $0M |
Trading halts
- 2025-09-03 14:08 UTC, code LUDP, resumed 14:13 UTC
- 2025-09-03 14:02 UTC, code LUDP, resumed 14:07 UTC
- 2025-02-21 15:06 UTC, code LUDP, resumed 15:11 UTC
- 2025-02-21 14:58 UTC, code LUDP, resumed 15:03 UTC
Fails to deliver
- : 212 shares at $1.74
- : 1 shares at $1.71
- : 87 shares at $1.56
- : 7 shares at $1.72
- : 450 shares at $1.82
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
SiNtx Technologies, Inc. scorecard#
Passes 2 of the 20 checks that could be worked out: strongest in financial health (1 of 3), weakest in valuation (0 of 5). Fiscal year 2025; market cap of Oct 30, 2026.
Valuation0 of 5
- ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
- ✗Price to book below its peers' median4.5×Price to book 4.5× against Medical Devices's median of 2.5×.
- ✗Price to sales below its peers' median12.9×Price to sales 12.9× against Medical Devices's median of 2.4×.
- ✗Free cash flow yield above 5%-66.5%Free cash flow is -66.5% of the market value.
- ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth1 of 6
- ✗Revenue grew in the newest year-64.7%Revenue down 64.7% in fiscal 2025.
- ✗Revenue up more than 5% a year over three years-13.2%-13.2% a year over the three years to fiscal 2025.
- ✗Faster growth over three years than its peers' median-13.2%-13.2% a year against Medical Devices's median of 10.8% (73 companies).
- ✗Earnings per share grew in the newest year-6.16 vs -15.19Diluted EPS -6.16 in fiscal 2025 against -15.19 the year before (report's currency).
- ✗Net income higher than five years earlier-$10 M-$10 M in fiscal 2025 against -$7 M in 2020.
- ✓Revenue rose in at least four of the last five years4 of 5Revenue rose in 4 of the five years to fiscal 2025.
Profitability0 of 3
- ✗Profitable in the newest year-$10 MNet income -$10 M in fiscal 2025.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
- –Operating margin above its peers' medianNo operating margin on file.
- ✗Return on equity above 15%-303.8%-303.8% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial health1 of 3
- ✓Short-term assets cover short-term liabilities1.5×Current ratio 1.51 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone-45.17Z-score -45.17 (distress zone) for fiscal 2025.
Shareholder returns0 of 3
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year272.4%Diluted shares up 272.4% in fiscal 2025.
- ✗Dividends and buybacks above 3% of the market value1.0%Dividends and buybacks were 1.0% of the market value.
- ✗Free cash flow covers dividends and buybacks-$9 MFree cash flow -$9 M against $0 M paid out in fiscal 2025.
Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from SiNtx Technologies, Inc.'s statements, beside the median of Medical Devices.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Return on equity | -303.8% | -16.8% | |
| Revenue growth, 3 years a year | -13.2% | 10.8% | |
| Revenue growth | -64.7% | 10.4% | |
| Free cash flow margin | -857.8% | -1.9% |
2of 8on the Piotroski tests of financial strength
- Revenue fell 64.7% against the year before.
- Net loss of $10 million, the 13th loss-making year in a row.
- Free cash flow was negative: -$9 million.
- The share count rose 272.4% in the year.
SiNtx Technologies, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 | FY 2018to Dec 31, 2018 | FY 2017to Dec 31, 2017 | FY 2016to Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 1.0−64.7%100% | 2.9+9.9%100% | 2.6+68.3%100% | 1.6+158%100% | 0.6+2.0%100% | 0.6−13.8%100% | 0.7+625%100% | 0.1−99.2%100% | 11−26.3%100% | 15—100% | |
| Cost of revenue | 0.6−31.3%54.7% | 0.8+3.4%28.1% | 0.8+196%29.8% | 0.3−41.0%17.0% | 0.4−5.5%74.1% | 0.5−13.8%80.0% | 0.6+884%80.0% | 0.1−99.1%58.9% | 6.4+68.2%56.6% | 3.8—24.8% | |
| Gross profit | 0.5−77.8%45.3% | 2.1+12.6%71.9% | 1.8+42.2%70.2% | 1.3+725%83.0% | 0.2+31.9%25.9% | 0.1−13.8%20.0% | 0.1+254%20.0% | 0.0−99.2%41.1% | 4.9−57.4%43.4% | 11—75.2% | |
| Research and development | 4.6−11.8%451% | 5.2−40.3%180% | 8.7+35.1%332% | 6.5+9.6%413% | 5.9+22.4%971% | 4.8+41.7%809% | 3.4+13.5%493% | 3.0−14.7%3148% | 3.5r5.1−44.7%31.2% | 6.3—41.7% | |
| Selling and marketing | 0.2−60.6%23.8% | 0.6−46.0%21.3% | 1.1−14.9%43.3% | 1.3+3.7%85.6% | 1.3+88.6%213% | 0.7+58.8%115% | 0.4+219%62.4% | 0.1−58.5%142% | 0.3r6.5−96.9%2.9% | 10—68.0% | |
| General and administrative | 6.2+55.0%609% | 4.0−5.3%138% | 4.2+5.8%161% | 4.0+10.7%256% | 3.6+15.0%595% | 3.1+7.7%527% | 2.9−24.8%422% | 3.9+5.8%4069% | 3.7r4.4−41.9%32.5% | 6.3—41.3% | |
| Operating expenses | 11−30.6%1098% | 16+6.1%558% | 15+20.3%579% | 13+17.2%809% | 11+25.0%1778% | 8.6+28.1%1452% | 6.7−48.8%977% | 13+75.8%13847% | 7.5r16−67.4%66.7% | 23—151% | |
| Operating income | −11—−1053% | −14—−487% | −13—−508% | −11—−726% | −11—−1752% | −8.5—−1432% | −6.6—−957% | −13—−13806% | −7.5r−11—−66.7% | −12—−75.8% | |
| Other non-operating income (expense) | 0.4−88.2%35.1% | 3.0−40.7%105% | 5.1—194% | −0.7−154%−45.1% | 1.3r1.8−11.1%216% | 1.5−17.9%248% | 1.8−47.6%261% | 3.4+98.8%3607% | 1.7—15.4% | −3.2r−5.1—−21.2% | |
| Income before tax | −10—−1018% | −11—−382% | −8.3—−314% | −12—−771% | −9.3r−8.8—−1536% | −7.0—−1183% | −4.8—−696% | −9.7—−10199% | −5.8r−9.3—−51.3% | −15r−17—−97.0% | |
| Income from discontinued operations | — | — | — | — | — | — | — | −0.3—−341% | — | — | |
| Net income attributable to shareholders | −10—−1018% | −11—−382% | −8.3—−314% | −12—−771% | −9.3r−8.8—−1536% | −7.0—−1183% | −4.8—−696% | −8.7—−9107% | −9.3—−83.1% | −15r−17—−97.0% | |
| Earnings per share, basic | -6.16—— | -14.87—— | -443.47r-2.22—— | -54.67—— | -37.70r-0.36—— | -1.01—— | -4.82—— | -61.85r-2.06—— | -3.13—— | -13.63r-1.23—— | |
| Earnings per share, diluted | -6.16—— | -15.19—— | -624.47r-3.13—— | -60.81—— | -39.91r-0.38—— | -1.08—— | -5.69—— | -76.73r-2.56—— | -3.13—— | -13.63r-1.23—— | |
| Shares, weighted average (basic) | 2.8+274%— | 0.7+3868%— | 0.0r3.7−93.8%— | 0.3+22.1%— | 0.2r25−98.5%— | 16+954%— | 1.6+327%— | 0.4r11−87.8%— | 3.0—— | — | |
| Shares, weighted average (diluted) | 2.8+272%— | 0.7+3319%— | 0.0r4.4−93.1%— | 0.3+26.6%— | 0.3r25−98.6%— | 17+1021%— | 1.6+305%— | 0.4r12−87.1%— | 3.0+93.0%— | 1.5r19—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 4.1+15.1%43.6% | 3.6+7.7%38.2% | 3.3−46.5%21.7% | 6.2−56.2%39.6% | 14−43.7%65.4% | 25+1319%83.3% | 1.8−67.2%19.5% | 5.4+911%47.3% | 0.5−92.2%3.7% | 6.9—26.3% | |
| Receivables | — | — | — | — | — | — | — | 0.3−78.8%2.3% | 1.2−23.5%8.5% | 1.6—6.2% | |
| Inventory | 0.8+64.3%8.7% | 0.5−43.5%5.3% | 0.9r1.2+20.5%5.8% | 0.7+23.5%4.7% | 0.6+22.6%2.7% | 0.5−23.8%1.6% | 0.6−5.5%7.0% | 0.7r0.6+0.1%5.9% | 0.7r2.4−90.6%4.6% | 7.2—27.5% | |
| Other current assets | 0.5+4970%5.3% | 0.0−87.5%0.1% | 0.1+900%0.5% | 0.0−97.7%0.1% | 0.4+44.0%1.6% | 0.2−21.6%0.8% | 0.3+81.3%3.4% | 0.2−10.0%1.5% | 0.2−20.5%1.3% | 0.2—0.9% | |
| Current assets | 5.7+25.0%59.4% | 4.5r4.8−18.3%48.0% | 5.5−23.3%36.0% | 7.2−52.0%45.7% | 15−45.5%68.8% | 28+579%90.6% | 4.1−42.1%44.4% | 7.0+91.1%60.9% | 3.7r3.2−77.0%25.1% | 16—60.9% | |
| Property, plant and equipment | 0.5−48.4%5.0% | 0.9−80.9%9.8% | 4.8−15.2%31.4% | 5.7+41.4%36.1% | 4.0+755%18.4% | 0.5+148%1.5% | 0.2+53.2%2.1% | 0.1−43.1%1.1% | 0.2r1.4−75.5%1.5% | 0.9—3.4% | |
| Right-of-use (leased) assets | 2.5−22.2%25.9% | 3.2−22.8%33.6% | 4.1+77.3%26.6% | 2.3−3.2%14.6% | 2.4+23.8%10.9% | 1.9−17.7%6.3% | 2.3—25.6% | — | — | — | |
| Goodwill | 0.3—3.2% | — | — | — | — | — | — | — | 6.20.0%42.1% | 6.2—23.5% | |
| Other intangible assets | 0.1+788%1.5% | 0.0−23.8%0.2% | 0.0−19.2%0.1% | 0.0−16.1%0.2% | 0.0−13.9%0.1% | 0.0−12.2%0.1% | 0.0−10.9%0.4% | 0.0−98.3%0.4% | 2.7−16.8%18.1% | 3.2—12.1% | |
| Total assets | 9.5+1.0%100% | 9.4−38.7%100% | 15−2.6%100% | 16−27.8%100% | 22−28.3%100% | 30+233%100% | 9.1−20.6%100% | 12−21.4%100% | 15−44.2%100% | 26—100% | |
| Accounts payable | 0.4+27.8%4.0% | 0.3−53.0%3.2% | 0.6+46.5%4.1% | 0.4+80.1%2.8% | 0.2r0.2+24.2%1.1% | 0.2+1.6%0.6% | 0.2−36.5%2.1% | 0.3−82.6%2.6% | 1.7+163%11.8% | 0.7—2.5% | |
| Debt due within a year | 0.0−78.1%0.1% | 0.0−30.4%0.3% | 0.0−71.3%0.3% | 0.2−68.6%1.0% | 0.5+367%2.3% | 0.1+1717%0.4% | 0.0—0.1% | — | 0.6−91.4%4.1% | 7.0—26.7% | |
| Current liabilities | 3.7+88.3%39.3% | 2.0−31.8%21.1% | 2.9−64.0%18.9% | 8.1+194%51.2% | 2.7r2.2−4.6%12.6% | 2.9+39.4%9.5% | 2.1−13.2%22.6% | 2.4−71.2%20.7% | 8.3−40.9%56.5% | 14r11—53.3% | |
| Long-term debt | — | — | — | 0.4—2.3% | — | 0.3+2292%0.9% | 0.0—0.1% | — | — | 12—45.3% | |
| Lease liabilities (non-current) | 2.8−19.6%29.9% | 3.5−4.1%37.6% | 3.7+127%24.0% | 1.6−14.6%10.3% | 1.9+28.5%8.7% | 1.5−20.9%4.9% | 1.9—20.4% | — | — | — | |
| Total liabilities | 6.6+19.2%69.2% | 5.5−16.3%58.6% | 6.6−34.5%42.9% | 10+117%63.8% | 4.6r4.1+0.0%21.3% | 4.6+17.7%15.2% | 3.9+26.6%43.1% | 3.1−66.1%27.1% | 9.2−38.8%62.8% | 15r12—57.2% | |
| Retained earnings | −292—−3073% | −282—−2993% | −271—−1762% | −262—−1664% | −250r−250—−1147% | −241—−792% | −234—−2559% | −229—−1991% | −221—−1507% | −211r−213—−805% | |
| Shareholders' equity | 2.9−24.8%30.8% | 3.9−55.6%41.4% | 8.8+53.8%57.1% | 5.7−66.8%36.2% | 17r18−33.4%78.7% | 26+396%84.8% | 5.2−38.1%56.9% | 8.4r8.4+54.3%72.9% | 5.4−51.6%37.2% | 11r14—42.8% | |
| Total liabilities and equity | 9.5+1.0%100% | 9.4−38.7%100% | 15−2.6%100% | 16−27.8%100% | 22−28.3%100% | 30+233%100% | 9.1−20.6%100% | 12−21.4%100% | 15−44.2%100% | 26—100% | |
| Shares outstanding | 4.0+196%— | 1.3+4948%— | 0.0r5.3−95.1%— | 0.5+119%— | 0.2r25−99.0%— | 25+909%— | 2.4+235%— | 0.7r22−76.0%— | 3.0+32.8%— | 2.3r27—— | |
| Cash-flow statement | |||||||||||
| Share-based compensation | 1.4+1595%137% | 0.1−71.8%2.8% | 0.3−21.1%11.1% | 0.4+19.4%23.6% | 0.3+587%51.0% | 0.0+2150%7.6% | 0.0−95.2%0.3% | 0.0−80.8%44.2% | 0.2−19.8%2.0% | 0.3—1.8% | |
| Cash from operating activities | −8.6—−842% | −8.6—−299% | −14—−537% | −10—−657% | −10r−10—−1671% | −9.1—−1534% | −6.4—−934% | −9.3—−9840% | −4.7—−41.7% | −7.2—−47.1% | |
| Capital expenditure | −0.2—−18.2% | −0.7—−23.9% | −0.5—−20.2% | −1.4—−90.0% | −3.7r−3.7—−618% | −0.4—−60.6% | −0.1—−21.3% | −0.0—−11.6% | −0.0r−1.2—−0.1% | −0.7—−4.4% | |
| Intangible assets bought | — | — | — | — | — | — | — | −0.1—−52.6% | — | — | |
| Cash from investing activities | 0.9—89.7% | −0.2—−6.7% | −0.5—−19.1% | −1.1—−70.5% | −1.7r−1.7−195%−273% | 1.8+26.8%295% | 1.4—200% | −0.1—−153% | −1.1—−10.1% | −0.6—−4.1% | |
| Debt issued | — | — | — | — | 0.5+25.4%84.0% | 0.4—68.4% | — | 0.7−71.8%742% | 2.5—22.3% | — | |
| Debt repaid | −0.2—−20.2% | −0.3—−12.1% | −0.1—−4.3% | −0.5—−32.6% | — | −0.0—−4.5% | −0.0—−0.4% | −2.3—−2402% | −6.8—−60.7% | −6.6—−43.5% | |
| Shares issued | 4.4−27.9%430% | 6.1+17.3%210% | 5.2—197% | — | — | 20+1278%3366% | 1.5—211% | — | 3.1+23.1%27.9% | 2.5r4.7—16.7% | |
| Shares bought back | −0.1—−13.1% | — | — | — | — | — | — | — | — | — | |
| Cash from financing activities | 8.2−9.8%806% | 9.1−22.3%315% | 12+251%446% | 3.3+373%214% | 0.7−97.7%116% | 31+2118%5206% | 1.4−90.3%202% | 14—15159% | −0.6−117%−5.0% | 3.2—21.1% | |
| Change in cash | 0.5+110%53.2% | 0.3—8.9% | −2.9—−111% | −8.0—−514% | −11−147%−1828% | 24—3967% | −3.7−175%−531% | 4.9—5166% | −6.4—−56.8% | −4.6—−30.0% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 3.3+161%100% | 2.2+953%100% | 0.5+199%100% | 0.4+3.0%100% | 0.3*−46.5%100% | 0.2−74.0%100% | 0.2−82.4%100% | 0.4−46.3%100% | 0.5*−39.9%100% | 0.8—100% | 0.9—100% | 0.7—100% | 0.9*—100% | |
| Cost of revenue | 1.3+120%40.5% | 0.8+620%37.8% | 0.2+85.1%38.5% | 0.2−4.1%62.1% | 0.1*−33.8%35.2% | 0.1−45.2%55.3% | 0.1−58.0%62.3% | 0.2+10.3%66.7% | 0.2*−65.4%28.4% | 0.2—26.3% | 0.2—26.1% | 0.2—32.5% | 0.4*—49.3% | |
| Gross profit | 2.0+198%59.5% | 1.4+1365%62.2% | 0.3+388%61.5% | 0.1+17.1%37.9% | 0.2*−51.5%64.8% | 0.1−84.2%44.7% | 0.1−91.0%37.7% | 0.1−73.5%33.3% | 0.4*−15.1%71.6% | 0.6—73.7% | 0.6—73.9% | 0.5—67.5% | 0.5*—50.7% | |
| Research and development | 2.5−43.3%74.1% | 0.5−56.6%25.0% | 0.6−53.7%127% | 0.4−67.4%95.8% | 1.0*+36.7%334% | 1.3+58.8%608% | 1.2−26.2%820% | 1.1−44.7%302% | 0.7*−61.1%131% | 0.8—99.6% | 1.7—195% | 2.0—294% | 1.8*—202% | |
| Selling and marketing | 1.0+663%28.8% | 0.1+137%6.4% | 0.3+1200%60.4% | 0.4+1895%105% | 0.1*+468%49.0% | 0.1−32.2%28.4% | 0.0r0.1−91.8%13.9% | 0.0r0.2−91.9%5.4% | 0.0*−90.4%4.6% | 0.1—10.9% | 0.3—29.8% | 0.2—35.8% | 0.3*—28.8% | |
| General and administrative | 8.5+45.0%256% | 2.3+7.1%103% | 2.3+63.8%513% | 2.5+92.2%667% | 1.4*+36.1%469% | 2.1+162%1011% | 1.4r1.3+32.0%937% | 1.3r1.2+17.5%357% | 1.0*+10.0%185% | 0.8—100% | 1.1—125% | 1.1—163% | 0.9*—101% | |
| Operating expenses | 12+11.3%363% | 3.0−13.1%137% | 3.2+16.3%700% | 3.4+33.7%882% | 2.5*+18.2%864% | 3.4−50.7%1658% | 2.7−18.6%1803% | 2.5−31.5%679% | 2.1*−33.3%391% | 7.0—876% | 3.3—389% | 3.7—533% | 3.2*—353% | |
| Operating income | −10—−303% | −1.6—−74.7% | −2.9—−639% | −3.2—−844% | −2.3*—−799% | −3.4—−1613% | −2.7—−1765% | −2.4—−646% | −1.7*—−320% | −6.4—−802% | −2.7—−315% | −3.2—−465% | −2.7*—−302% | |
| Other non-operating income (expense) | 0.7+144%21.5% | 0.0—1.8% | 0.2−47.6%40.3% | 0.4+324%102% | 0.1*+178%35.5% | −0.2−209%−88.5% | 0.3−31.4%230% | 0.1−96.1%24.7% | 0.0*−90.8%6.8% | 0.2—21.2% | 0.5—58.9% | 2.3—336% | 0.4*—44.6% | |
| Income before tax | −9.3—−282% | −1.6—−72.8% | −2.7—−599% | −2.8—−742% | −2.2*—−764% | −3.5—−1701% | −2.3—−1535% | −2.3—−621% | −1.7*—−313% | −6.2—−781% | −2.2—−257% | −0.9—−129% | −2.3*—−257% | |
| Net income attributable to shareholders | −9.3—−282% | −1.6—−72.8% | −2.7—−599% | −2.8—−742% | −2.2*—−764% | −3.5—−1701% | −2.3—−1535% | −2.3—−621% | −1.7*—−313% | −6.2—−781% | −2.2—−257% | −0.9—−129% | −2.3*—−257% | |
| Earnings per share, basic | — | -0.24—— | -0.75—— | -0.70—— | — | -3.46—— | -0.91—— | -1.29—— | — | -6.96—— | -3.49—— | -10.26r-0.05—— | — | |
| Earnings per share, diluted | — | -0.24—— | -0.75—— | -0.70—— | — | -3.46—— | -0.91—— | -1.29—— | — | -6.96—— | -3.61—— | -21.66r-0.11—— | — | |
| Shares, weighted average (basic) | 6.7+125%— | 6.7+125%— | 4.8+91.3%— | 4.0+126%— | — | 3.0+231%— | 2.5+302%— | 1.8+1954%— | — | 0.9—— | 0.6—— | 0.1r17—— | — | |
| Shares, weighted average (diluted) | 6.7+125%— | 6.7+125%— | 4.8+91.3%— | 4.0+126%— | — | 3.0+230%— | 2.5+263%— | 1.8+930%— | — | 0.9—— | 0.7—— | 0.2r34—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 2.0—22.5% | 2.0−67.9%22.5% | 3.6−16.9%34.4% | 1.9−70.9%24.2% | 4.1+15.1%43.6% | 6.3+29.8%55.0% | 4.3−5.2%47.0% | 6.5+12.8%56.8% | 3.6+7.7%38.2% | 4.8—42.6% | 4.6—29.8% | 5.8—32.8% | 3.3—21.7% | |
| Inventory | 2.6—28.7% | 2.6+472%28.7% | 2.3+534%21.6% | 1.4+228%17.8% | 0.8+64.3%8.7% | 0.4−3.5%3.9% | 0.4−65.2%3.9% | 0.4−63.9%3.7% | 0.5−43.5%5.3% | 0.5—4.1% | 1.0—6.7% | 1.2—6.7% | 0.9r1.2—5.8% | |
| Other current assets | 0.8—9.3% | 0.8+43.7%9.3% | 0.9+1798%8.2% | 0.7+3285%8.7% | 0.5+4970%5.3% | 0.6+381%5.1% | 0.0+9.8%0.5% | 0.0−89.8%0.2% | 0.0−87.5%0.1% | 0.1—1.1% | 0.0—0.3% | 0.2—1.1% | 0.1—0.5% | |
| Current assets | 5.5—62.0% | 5.5−25.3%62.0% | 7.0+26.6%67.4% | 4.3−43.2%55.4% | 5.7+25.0%59.4% | 7.4+16.8%65.1% | 5.5−5.3%60.3% | 7.6+1.4%66.5% | 4.5r4.8−18.3%48.0% | 6.3—56.0% | 5.9—38.3% | 7.5—42.8% | 5.5—36.0% | |
| Property, plant and equipment | 0.5—5.8% | 0.5+2.2%5.8% | 0.4−13.0%4.2% | 0.4−27.8%5.3% | 0.5−48.4%5.0% | 0.5−51.6%4.5% | 0.5−89.6%5.4% | 0.6−88.6%5.0% | 0.9−80.9%9.8% | 1.0—9.3% | 4.8—31.5% | 5.1—28.8% | 4.8—31.4% | |
| Right-of-use (leased) assets | 2.2—24.9% | 2.2−12.7%24.9% | 2.3−12.1%22.0% | 2.4−11.5%30.4% | 2.5−22.2%25.9% | 2.5−22.4%22.3% | 2.6−31.1%28.4% | 2.7−31.7%23.5% | 3.2−22.8%33.6% | 3.3—28.9% | 3.8—24.8% | 3.9—22.4% | 4.1—26.6% | |
| Goodwill | 0.3—3.4% | 0.30.0%3.4% | 0.3—2.9% | 0.3—3.9% | 0.3—3.2% | 0.3—2.7% | — | — | — | — | — | — | — | |
| Other intangible assets | 0.1—1.3% | 0.1−22.7%1.3% | 0.1+793%1.2% | 0.1+787%1.7% | 0.1+788%1.5% | 0.2+782%1.3% | 0.0−26.3%0.2% | 0.0−25.0%0.1% | 0.0−23.8%0.2% | 0.0—0.2% | 0.0—0.1% | 0.0—0.1% | 0.0—0.1% | |
| Total assets | 8.9—100% | 8.9−21.7%100% | 10+13.4%100% | 7.8−31.8%100% | 9.5+1.0%100% | 11+0.5%100% | 9.2−39.9%100% | 11−34.8%100% | 9.4−38.7%100% | 11—100% | 15—100% | 18—100% | 15—100% | |
| Accounts payable | 1.0—10.8% | 1.0+373%10.8% | 0.9+410%9.0% | 0.6+30.4%7.3% | 0.4+27.8%4.0% | 0.2+32.7%1.8% | 0.2−44.7%2.0% | 0.4−2.2%3.8% | 0.3−53.0%3.2% | 0.2—1.4% | 0.3—2.2% | 0.4—2.6% | 0.6—4.1% | |
| Customer deposits | — | — | — | — | — | 1.8—15.8% | 0.8—8.2% | — | — | — | — | — | — | |
| Debt due within a year | 0.1—0.6% | 0.1−6.8%0.6% | 0.1−6.4%1.0% | 0.1−19.1%1.4% | 0.0−78.1%0.1% | 0.1−56.0%0.5% | 0.1−54.8%1.2% | 0.1−43.8%1.1% | 0.0−30.4%0.3% | 0.1—1.2% | 0.2—1.6% | 0.2—1.3% | 0.0—0.3% | |
| Current liabilities | 3.0—33.7% | 3.0−30.9%33.7% | 3.0+38.0%28.5% | 4.2+88.7%53.4% | 3.7+88.3%39.3% | 4.3+109%38.3% | 2.2−28.6%23.5% | 2.2−45.9%19.3% | 2.0−31.8%21.1% | 2.1—18.4% | 3.0—19.8% | 4.1—23.3% | 2.9—18.9% | |
| Lease liabilities (non-current) | 2.5—28.2% | 2.5−14.9%28.2% | 2.6−14.0%25.1% | 2.7−13.1%35.0% | 2.8−19.6%29.9% | 2.9−19.0%26.0% | 3.0−11.1%33.2% | 3.1−11.3%27.5% | 3.5−4.1%37.6% | 3.6—32.2% | 3.4—22.4% | 3.5—20.2% | 3.7—24.0% | |
| Total liabilities | 5.5—61.9% | 5.5−24.4%61.9% | 5.6+7.5%53.7% | 6.9+28.9%88.4% | 6.6+19.2%69.2% | 7.3+27.5%64.2% | 5.2−19.3%56.6% | 5.4−29.8%46.8% | 5.5−16.3%58.6% | 5.7—50.6% | 6.5—42.2% | 7.6—43.5% | 6.6—42.9% | |
| Retained earnings | −299—−3361% | −299—−3361% | −298—−2854% | −295−201%−3776% | −292—−3073% | −290—−2551% | −286—−3114% | 292r−284—2550% | −282—−2993% | −280—−2478% | −274—−1790% | −272—−1547% | −271—−1762% | |
| Shareholders' equity | 3.4—38.1% | 3.4−16.7%38.1% | 4.8+21.1%46.3% | 0.9−85.2%11.6% | 2.9−24.8%30.8% | 4.1−27.1%35.8% | 4.0−54.9%43.4% | 6.1−38.6%53.2% | 3.9−55.6%41.4% | 5.6—49.4% | 8.8—57.8% | 9.9—56.5% | 8.8—57.1% | |
| Total liabilities and equity | 8.9—100% | 8.9−21.7%100% | 10+13.4%100% | 7.8−31.8%100% | 9.5+1.0%100% | 11+0.5%100% | 9.2−39.9%100% | 11−34.8%100% | 9.4−38.7%100% | 11—100% | 15—100% | 18—100% | 15—100% | |
| Shares outstanding | 6.9—— | 6.9+90.5%— | 6.6+166%— | 4.1+65.6%— | 4.0+196%— | 3.6+169%— | 2.5+232%— | 2.5−95.1%— | 1.3+4948%— | 1.3—— | 0.7—— | 51—— | 0.0r5.3—— | |
| Cash-flow statement | ||||||||||||||
| Share-based compensation | 1.8+138%53.5% | 0.3*−49.6%12.6% | 0.3*+81.1%70.1% | 0.5+2844%139% | 0.7*+9200%224% | 0.5*+5360%263% | 0.2*+1067%116% | 0.0−64.0%4.9% | 0.0*−89.6%1.3% | 0.0*—1.3% | 0.0*—1.7% | 0.1—7.3% | 0.1*—7.4% | |
| Cash from operating activities | −9.0—−271% | −1.4*—−62.5% | −2.8*—−612% | −2.5—−656% | −2.3*—−808% | −2.5*—−1210% | −2.4*—−1595% | −1.3—−353% | −1.1*—−207% | −2.6*—−322% | −2.2*—−258% | −2.7—−398% | −3.1*—−347% | |
| Capital expenditure | −0.3—−8.4% | −0.1*—−6.6% | −0.1*—−18.6% | −0.0—−1.8% | −0.0*—−14.5% | −0.1*—−40.4% | 0*—0.0% | −0.1—−16.0% | −0.1*—−26.9% | −0.0*—−1.4% | −0.4*—−41.8% | −0.2—−25.3% | −0.1*—−8.2% | |
| Acquisitions, net of cash acquired | — | — | — | — | — | — | — | −0.0—−1.1% | — | — | — | — | — | |
| Cash from investing activities | −0.3−129%−8.4% | −0.1*−122%−6.6% | −0.1*−124%−18.6% | −0.0—−1.8% | −0.0*−520%−14.5% | 0.7*—320% | 0.4*—233% | −0.1—−17.1% | 0.0*—1.8% | −0.0*—−3.9% | 0*—0.0% | −0.2—−25.2% | −0.1*—−6.9% | |
| Debt repaid | −0.2—−4.9% | −0.0*—−2.1% | −0.0*—−9.3% | −0.0—−5.0% | −0.1*—−18.3% | −0.1*—−24.0% | −0.1*—−37.1% | −0.0—−12.7% | −0.1*—−18.8% | −0.1*—−13.3% | −0.1*—−11.5% | −0.0—−6.1% | −0.0*—−2.9% | |
| Shares issued | — | −0.0*−2500%−1.1% | — | — | 0*—0.0% | 0.0*−100.0%0.5% | −0.0*−102%−13.2% | 4.4+120%1192% | 0*−100%0.0% | 3.0*—371% | 1.1*—129% | 2.0—292% | 0.3*—37.4% | |
| Shares bought back | — | — | — | — | 0*—0.0% | 0*—0.0% | −0.0*—−31.1% | −0.1—−23.3% | — | — | — | — | — | |
| Cash from financing activities | 5.0−36.0%151% | −0.1*−102%−3.3% | 4.6*—1007% | 0.2−94.2%65.0% | 0.3*—95.2% | 3.8*+32.3%1818% | −0.1*−112%−81.5% | 4.3−19.9%1156% | −0.1*−133%−18.8% | 2.9*—358% | 1.0*—118% | 5.3—776% | 0.3*—34.5% | |
| Change in cash | −4.2−396%−128% | −1.6*−182%−72.4% | 1.7*—376% | −2.3−178%−592% | −2.1*—−728% | 1.9*+651%928% | −2.2*—−1444% | 2.9+19.8%786% | −1.2*—−224% | 0.3*—32.2% | −1.2*—−140% | 2.4—353% | −2.9*—−319% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What SiNtx Technologies, Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Products and services
- Product(total)$1 M72%-42%
- Grant and Contract$0 M28%-82%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Executive pay at SiNtx Technologies, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2025Eric Olson | $1.1 M | $1.0 M | $753 K | — |
| 2023Eric K. Olson | $537 K | $462 K | $454 K | — |
Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025
Events at SiNtx Technologies, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Warning signs in the last three years
- Delisting noticeFiling
Delisting notice 1 · Directors and officers 8 · Material agreement 7 · Unregistered share sale 5 · Shareholder vote 2 · Results announced 5
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Delisting notice | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Material agreement | 8-K | |
| Shareholder vote | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 5, 2026
Acquisitions and funding#
5 private funding rounds before listing
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jun 2014 | $6 M | No. 5 | $2 to $10 million | 1 | debt, options | SEC |
| Aug 2013 | $9 M | No. 4 | $2 to $10 million | 45 | equity, options | SEC |
| Feb 2013 | $3 M | No. 3 | $2 to $10 million | 34 | equity, options | SEC |
| Mar 2011 | $22 M | No. 2 | $10 to $50 million | 69 | debt, options | SEC |
| Feb 2010 | $11 M | No. 1 | $10 to $50 million | 96 | equity | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
From US state WARN notices and SEC 8-K restructuring filings, newest first.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | · | · | · | · | · | · | · | · | · | 21 | · | · | 21 |
| 2015 | 25 | · | · | · | · | · | · | · | · | · | · | · | 25 |
| Announced | People | Kind | Where | Source |
|---|---|---|---|---|
| 21 people (38% of workforce) | Restructuring planSEC 8-K | “On October 3, 2016, the Board of Directors of Amedica Corporation authorized the implementation of certain cost saving measures which included a reduction in staff of 21 employees,…” | Filing | |
| 25 people (28% of workforce) | Restructuring planSEC 8-K | “On January 7, 2015, the Board of Directors of Amedica Corporation authorized the implementation of certain cost saving measures which included a reduction in staff of 25 employees,…” | Filing |
Source: State WARN notices and SEC 8-K item 2.05
How SiNtx Technologies, Inc. compares in Medical Devices
- Market cap$13 M · higher than 8% of 142
- Revenue$1 M · higher than 7% of 155
- Revenue growth-64.7% · higher than 2% of 104
- Price / sales12.9× · lower than 6% of 96
- Price / book4.5× · lower than 33% of 99
- FCF yield-66.5% · higher than 9% of 76
Peer comparison · Medical Devices
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| SiNtx Technologies, Inc.🇺🇸 | $13 M | — | — | -64.7% |
| Abbott Laboratories🇺🇸 | $181.1 B | 38.5× | 9.8% | +5.7% |
| Medtronic plc🇺🇸 | $121.2 B | 23.2× | 13.9% | +8.4% |
| Stryker Corporation🇺🇸 | $116.5 B | 32.2× | 13.8% | +11.2% |
| Boston Scientific Corporation🇺🇸 | $66.2 B | 18.9× | 16.6% | +19.9% |
| Edwards Lifesciences Corporation🇺🇸 | $52.8 B | 51.7× | 15.3% | +11.6% |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳 | $27.8 B | 23.6× | 24.4% | — |
| STERIS plc🇮🇪 | $20.4 B | 24.6× | 13.4% | +8.7% |
| Zimmer Biomet Holdings, Inc.🇺🇸 | $18.2 B | 23.8× | 8.9% | +7.2% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Health & Life$12 M
- Flyte Aviation, Inc.$15 M
- Ventripoint Diagnostics Ltd.$11 M
- PAVmed Inc.$16 M
- EPS Bio Technology Corp.$10 M
- Lifeward Ltd.$17 M
Sources and freshness
- Market cap:
- Oct 30, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As of December 31, 2025
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report, GLEIF register; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at SiNtx Technologies, Inc.? Verify and update this profile — free
Show SiNtx Technologies, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.